Archive · 23 May 2025
Diabetes Research: MDRF and Russia’s Almazov Centre Team Up
The Madras Diabetes Research Foundation (MDRF) and Russia's Almazov National Medical Research Centre are teaming up to fight diabetes.
They signed an agreement to work together on new ways to diagnose and treat the disease, particularly gestational diabetes, which affects pregnant women.
They'll also look at how to use artificial intelligence (AI) and precision medicine to better manage diabetes.
This partnership includes joint research, exchanging scientists, and publishing their findings together.
A keynote on AI in diabetes was also given at a forum, and research on gestational diabetes has already started with teams from both organizations.
MDRF and Almazov Centre signed an MoU for collaborative diabetes research.
The partnership will focus on new diagnostic and treatment strategies.
Gestational diabetes mellitus is a key area of focus.
AI and precision medicine will be explored for diabetes management.
The agreement includes joint research, exchanges, and training.
- Who
- Madras Diabetes Research Foundation and Almazov National Medical Research Centre
- What
- Signed a MoU to advance collaborative research in diabetes care
- When
- May 23, 2025
- Where
- Saint Petersburg, Russia
- Why
- To advance research and improve diabetes care.
- Organizations Involved
- Madras Diabetes Research Foundation (MDRF) and Almazov National Medical Research Centre
- Location of Almazov Centre
- Saint Petersburg, Russia
- Purpose of MoU
- Collaborative research in diabetes care
- Specific Focus
- Gestational diabetes mellitus
- Agreement Components
- Joint research projects, academic exchanges, collaborative publications, and training programmes